Investment Summary

Quilvest Capital Partners Invests In Tiendas 3B

On May 1, 2004, private equity firm Quilvest Capital Partners invested in retailer Tiendas 3B

Investment Highlights
  • This is Quilvest Capital Partners’ 2nd transaction in the Retail sector.
  • This is Quilvest Capital Partners’ 1st transaction in Mexico.

Investment Summary
Date 2004-05-01
Target Tiendas 3B
Sector Retail
Investor(s) Quilvest Capital Partners
Deal Type Stake Purchase

Target

Tiendas 3B

Mexico City, Mexico
Tiendas 3B is a chain of hard-discount grocery stores in Mexico, modeled on the typical European hard-discounters’ operations: limited product selection (allowing for more volume discounts from suppliers, and lower logistics costs), small stores with low rents and limited staff. Tiendas 3B operates its own distribution centers and is geographically focused on Mexico City and its suburbs.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Quilvest Capital Partners

Paris, France

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1972
PE ASSETS 6.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Quilvest Capital Partners is the private equity investment arm of asset management firm Quilvest. Quilvest Capital Partners invests in private equity and debt funds as well as makes direct investments. The direct investment group looks for opportunities in the US, Europe, and 'opportunistically' in Asia with a preference for buyout, growth capital, and venture transactions. Quilvest Capital Partners will consider both minority and majority positions. Quilvest Capital Partners was established in 1972 and is based Paris.

DEAL STATS #
Overall 17 of 98
Sector (Retail) 2 of 4
Type (Stake Purchase) 6 of 25
Country (Mexico) 1 of 1
Year (2004) 3 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-05-01 Integral Press SA

Spain

Integral Press is a leading company in newspaper printing, with four rotary printers with the capacity to print 2 million units per day.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-06-01 Salmedix

San Diego, California, United States

Salmedix was a late stage biopharmaceutical company focusing on in-licensing and development of cancer products. The Company?s lead product, SDX-105, was in Phase II/III clinical trials for non-Hodgkin?s lymphoma at the time of Easton's investment. In addition, Salmedix had two drugs in Phase II clinical development, as well as several preclinical product candidates.

Buy -
Mergr

Product

Company

Legal